Phase 1 Sinusitis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray
Chronic Rhinosinusitis (CRS)
VivaVision Biotech, Inc60 enrolled1 locationNCT07259538
Recruiting
Phase 1Phase 2
Effectiveness of Penthrox vs Placebo in Sinus Procedures, a Clinical Trial
Chronic Rhinosinusitis (CRS)
St. Paul's Hospital, Canada100 enrolled1 locationNCT06750302
Completed
Phase 1
Investigation of Nasal Deposition using a Medical Device (Nasal Mesh Nebuliser -NMN)
chronic rhino-sinusitis
AFT Pharmaceuticals Ltd.20 enrolled1 locationACTRN12618000693224
Recruiting
Phase 1
Effect of novel drug with Chitodex gel on wound healing post endoscopic sinus surgery in the treatment of Chronic Rhinosinusitis (CRS)
Chronic recalcitrant sinusitis
The University of Adelaide90 enrolled1 locationACTRN12618000577213